MyHC |
myosin heavy chain |
Myf5 |
myogenic factor 5 |
MyoD |
myoblast determination protein 1 |
Pax7 |
paired box protein 7 |
Mesp1 |
mesoderm posterior 1 |
ISl1 |
insulin gene enhancer protein |
IGF-1 |
insulin-like growth factor 1 |
mTOR |
mammalian target of rapamycin |
mTORC1 |
mammalian target of rapamycin complex 1 |
mTORC2 |
mammalian target of rapamycin complex 2 |
PI3K |
phosphoinositide 3-kinase |
AMP |
adenosine monophosphate |
AMPK |
adenosine monophosphate -activated protein kinase |
eIF4E |
eukaryotic translation initiation factor 4E |
4EBP1 |
eukaryotic translation initiation factor 4E-binding protein 1 |
S6K1 |
ribosomal protein S6 kinase-1 |
IL-6 |
interleukin-6 |
TGF-β |
transforming growth factor β |
FGF |
fibroblast growth factor |
JAK2 |
janus kinase 2 |
STAT3 |
signal transducer and activator of transcription 3 |
MuRF-1 |
muscle ring finger 1 |
Foxo |
forkhead box O |
NF-ĸB |
nuclear factor kappa-light-chain-enhancer of activated B cells |
TNF-α |
Tumor necrosis factor α |
JNK |
c-jun N-terminal kinase |
PGC1-α |
peroxisome proliferator-activated receptor gamma coactivator 1 |
Cbl-b |
casitas B-lineage lymphoma-b |
IRS-1 |
insulin receptor substrate-1 |
ActRIIB |
activin type II B receptors |
CDK2 |
cyclin-dependent kinase 2 |
RJ |
royal jelly |
10H2DA |
trans-10-hydroxy-2-decenoic acid |
10HDAA |
10-hydroxydecanoic acid |
pRJ |
protease-treated royal jelly |
HDAC |
histone deacetylase |
GLUT4 |
glucose transporter type 4 |
GGOH |
geranylgeraniol |
GRAS |
generally recognized as safe |
GGPP |
geranylgeranylpyrophosphate |
LPS |
lipopolysaccharide |
ER |
estrogen receptors |
ROS |
reactive oxygen species |
TRPV1 |
transient receptor potential vanilloid 1 |
VDR |
Vitamin D receptor |